Radient Technologies Inc
XTSX:RTI
Operating Margin
Radient Technologies Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Radient Technologies Inc
XTSX:RTI
|
2.7m CAD |
-200%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
715.6B USD |
40%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
366.8B USD |
26%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
48%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
206.8B CHF |
33%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
179.4B CHF |
33%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
160.8B GBP |
24%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
194.3B USD |
34%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
130.8B USD |
27%
|
Radient Technologies Inc
Glance View
Radient Technologies, Inc. engages in manufacture of natural ingredients in the food and beverage, nutrition and supplements, pharmaceuticals, and active care industries. The company is headquartered in Edmonton, Alberta. The company went IPO on 2011-08-24. The firm's principal activities are research, development and commercialization of technology for the extraction, isolation and purification of soluble products from a range of materials using microwave technology. The firm is focused on the formulation, manufacturing and launching of cannabis products. The company develops specialty products that contains a range of cannabinoid and terpene profiles. The company also operates a scientific and product testing laboratory that offers solutions to the cannabis and wellness spaces. Its extraction platform extracts cannabinoids from cannabis and hemp biomass. Its cannabis formulations include tinctures, topicals, sub-lingual sprays, standardized oils, stable water soluble and water dispersible powders and solid powders. Its cannabinoid-based ingredients are formulated for use in food and beverage products, personal care products and others.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Radient Technologies Inc's most recent financial statements, the company has Operating Margin of -200.5%.
You don't have any saved screeners yet